These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 27027272)

  • 1. Treatment of Cannabis Use Disorder: Current Science and Future Outlook.
    Sherman BJ; McRae-Clark AL
    Pharmacotherapy; 2016 May; 36(5):511-35. PubMed ID: 27027272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological Treatment of Cannabis-Related Disorders: A Narrative Review.
    Gorelick DA
    Curr Pharm Des; 2016; 22(42):6409-6419. PubMed ID: 27549375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is There a Place for Off-Label Pharmacotherapy in Cannabis Use Disorder? A Review on Efficacy and Safety.
    Laprevote V; Schwan R; Schwitzer T; Rolland B; Thome J
    Curr Pharm Des; 2015; 21(23):3298-305. PubMed ID: 26088109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A proof-of-concept randomized controlled study of gabapentin: effects on cannabis use, withdrawal and executive function deficits in cannabis-dependent adults.
    Mason BJ; Crean R; Goodell V; Light JM; Quello S; Shadan F; Buffkins K; Kyle M; Adusumalli M; Begovic A; Rao S
    Neuropsychopharmacology; 2012 Jun; 37(7):1689-98. PubMed ID: 22373942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of cannabis use among people with psychotic or depressive disorders: a systematic review.
    Baker AL; Hides L; Lubman DI
    J Clin Psychiatry; 2010 Mar; 71(3):247-54. PubMed ID: 20331929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depressive symptoms and cannabis use in a placebo-controlled trial of N-Acetylcysteine for adult cannabis use disorder.
    Tomko RL; Baker NL; Hood CO; Gilmore AK; McClure EA; Squeglia LM; McRae-Clark AL; Sonne SC; Gray KM
    Psychopharmacology (Berl); 2020 Feb; 237(2):479-490. PubMed ID: 31712969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults.
    Gray KM; Sonne SC; McClure EA; Ghitza UE; Matthews AG; McRae-Clark AL; Carroll KM; Potter JS; Wiest K; Mooney LJ; Hasson A; Walsh SL; Lofwall MR; Babalonis S; Lindblad RW; Sparenborg S; Wahle A; King JS; Baker NL; Tomko RL; Haynes LF; Vandrey RG; Levin FR
    Drug Alcohol Depend; 2017 Aug; 177():249-257. PubMed ID: 28623823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network.
    McClure EA; Sonne SC; Winhusen T; Carroll KM; Ghitza UE; McRae-Clark AL; Matthews AG; Sharma G; Van Veldhuisen P; Vandrey RG; Levin FR; Weiss RD; Lindblad R; Allen C; Mooney LJ; Haynes L; Brigham GS; Sparenborg S; Hasson AL; Gray KM
    Contemp Clin Trials; 2014 Nov; 39(2):211-23. PubMed ID: 25179587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging pharmacotherapy for the treatment of cannabis use disorder.
    Shamabadi A; Arabzadeh Bahri R; Karimi H; Heidari E; Akhondzadeh S
    Expert Opin Pharmacother; 2024 Apr; 25(6):695-703. PubMed ID: 38717605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Separate and combined effects of gabapentin and [INCREMENT]9-tetrahydrocannabinol in humans discriminating [INCREMENT]9-tetrahydrocannabinol.
    Lile JA; Wesley MJ; Kelly TH; Hays LR
    Behav Pharmacol; 2016 Apr; 27(2-3 Spec Issue):215-24. PubMed ID: 26313650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Adolescent Cannabis Use Disorders.
    Adams ZW; Marriott BR; Hulvershorn LA; Hinckley JD
    Psychiatr Clin North Am; 2023 Dec; 46(4):775-788. PubMed ID: 37879838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. State of the art treatments for cannabis dependence.
    Danovitch I; Gorelick DA
    Psychiatr Clin North Am; 2012 Jun; 35(2):309-26. PubMed ID: 22640758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Adolescent Cannabis Use Disorders.
    Adams ZW; Marriott BR; Hulvershorn LA; Hinckley J
    Child Adolesc Psychiatr Clin N Am; 2023 Jan; 32(1):141-155. PubMed ID: 36410901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When and How to Treat Possible Cannabis Use Disorder.
    Lévesque A; Le Foll B
    Med Clin North Am; 2018 Jul; 102(4):667-681. PubMed ID: 29933822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review of outcome domains and measures used in psychosocial and pharmacological treatment trials for cannabis use disorder.
    Lee DC; Schlienz NJ; Peters EN; Dworkin RH; Turk DC; Strain EC; Vandrey R
    Drug Alcohol Depend; 2019 Jan; 194():500-517. PubMed ID: 30530238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychosocial and pharmacological interventions for the treatment of cannabis use disorder.
    Sabioni P; Le Foll B
    F1000Res; 2018; 7():173. PubMed ID: 29497498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabis use and cannabis use disorder.
    Connor JP; Stjepanović D; Le Foll B; Hoch E; Budney AJ; Hall WD
    Nat Rev Dis Primers; 2021 Feb; 7(1):16. PubMed ID: 33627670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychosocial and pharmacological treatments for cannabis use disorder and mental health comorbidities: a narrative review.
    Lees R; Hines LA; D'Souza DC; Stothart G; Di Forti M; Hoch E; Freeman TP
    Psychol Med; 2021 Feb; 51(3):353-364. PubMed ID: 33536109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low Pretreatment Impulsivity and High Medication Adherence Increase the Odds of Abstinence in a Trial of N-Acetylcysteine in Adolescents with Cannabis Use Disorder.
    Bentzley JP; Tomko RL; Gray KM
    J Subst Abuse Treat; 2016 Apr; 63():72-7. PubMed ID: 26827257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CANDIS treatment program for cannabis use disorders: findings from a randomized multi-site translational trial.
    Hoch E; Bühringer G; Pixa A; Dittmer K; Henker J; Seifert A; Wittchen HU
    Drug Alcohol Depend; 2014 Jan; 134():185-193. PubMed ID: 24176199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.